Samarth Kulkarni, CEO: Crispr Therapeutics CRSP Sell · Filed 24/01/31

Trade details

Type: Insider sale
Amount: $2,982,650
Shares · price: 49,300 sh · $60.50 a share
Held after: 188,077 sh
Stock: Crispr Therapeutics CRSP
Person: Samarth KulkarniCEO
Trade date: 24/01/29
Filed: 24/01/31
Days to filing: 2 days

Sold 20.8% of holdings

Share of holding sold: 20.8%

Crispr Therapeutics trades, last 26 weeks

What else happened in Crispr Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/30~24/02/28

Samarth Kulkarni's recent trades

Samarth KulkarniCEO
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$468.7K
10,020 sh
$468.7K
Filed 03/24
Traded 03/23
Samarth KulkarniCEO
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$499.4K
10,349 sh
$499.4K
Filed 03/17
Traded 03/16
Samarth KulkarniCEO
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$517.3K
9,798 sh
$517.3K
Filed 03/12
Traded 03/11
Samarth KulkarniCEO
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$366.3K
6,967 sh
$366.3K
Filed 02/20
Traded 02/19
Samarth KulkarniCEO
Sell10b5-1 planCrispr Therapeutics
Sell10b5-1 plan
Crispr Therapeutics
CRSP
$3.6M
60,000 sh
$3.6M
Filed 01/22
Traded 01/22

Samarth Kulkarni, CEO — sold $3M of Crispr Therapeutics CRSP · 20.8% of holdings · 10b5-1 plan | Whalegun